Abstract
Infectious diseases frequently affect the peripheral nervous system by direct infiltration or indirect inflammatory response induced by the microorganisms. Peripheral neuropathies are commonly observed in the course of HIV infection and represent the major neurological complication of the disease. The heterogeneous spectrum makes the diagnosis challenging even for the expert neurologist and includes distal symmetric neuropathies, demyelinating neuropathies, mononeuritis multiplex, progressive polyradiculopathies, and diffuse infiltrative lymphocytosis syndrome. Peripheral neuropathy (PN) is one of the most frequently reported extrahepatic complications of HCV chronic infection, occurring in about 10% of HCV-infected patients. PN usually coexists with cryoglobulinemia and may manifest as chronic “length dependent” distal symmetrical sensorimotor or mainly sensory axonal polyneuropathy, “stocking-glove” asymmetric polyneuropathy, subacute mononeuropathy multiplex, or asymmetrical neuropathy involving large or small nerve fibers. Pure motor or demyelinating neuropathies and, rarely, cranial or autonomic neuropathies, have also been reported. Among the rarest causes of infectious neuropathies, leprosy and borreliosis are an important global health concern. The differential diagnosis is often difficult and sometimes, in particular in suspected neuritic form of leprosy, requires nerve biopsy and a detailed neuropathological analysis that can help for personalized therapy. With the COVID-19 pandemic, many cases of patients with peripheral nervous system involvement have been described, in the absence of a direct role of SARS-CoV-2.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Sansonno D, Dammacco F. Hepatitis C virus, cryoglobulinaemia, and vasculitis: immune complex relations. Lancet Infect Dis. 2005;5:227–36.
Robbins SJ, Shaheen AAM, Myers RP. Immunologic complications of the hepatitis C virus. Curr Hepatitis Rep. 2007;6:138–44.
Bonetti B, Invernizzi F, Rizzuto N, et al. T-cell-mediated epineurial vasculitis and humoral-mediated microangiopathy in cryoglobulinemic neuropathy. J Neuroimmunol. 1997;73:145–54.
Vital C, Vital A, Canron MH, et al. Combined nerve and muscle biopsy in the diagnosis of vasculitic neuropathy. A 16-year retrospective study of 202 cases. J Peripher Nerv Syst. 2006;11:20–9.
Bonetti B, Scardoni M, Rizzuto N, et al. Hepatitis C virus infection of peripheral nerves in type II cryoglobulinaemia. Virchows Arch. 1999;434:533–5.
De Martino L, Sampaolo S, Tucci C, et al. Viral RNA in nerve tissues of patients with hepatitis C infection and peripheral neuropathy. Muscle Nerve. 2003;27:102–4.
Russi S, Sansonno D, Monaco S, et al. HCV RNA genomic sequences and HCV-E2 glycoprotein in sural nerve biopsies from HCV-infected patients with peripheral neuropathy. Neuropathol Appl Neurobiol. 2018;44:427–38.
Yoon MS, Obermann M, Dockweiler C, et al. Sensory neuropathy in patients with cryoglobulin negative hepatitis- C infection. J Neurol. 2011;258:80–8.
Bant A, Hurowitz B, Hassan N, et al. Complex regional pain syndrome (reflex sympathetic dystrophy) in a patient with essential mixed cryoglobulinemia and chronic hepatitis C. J Pak Med Assoc. 2007;57:96–8.
Biasiotta A, Casato M, La Cesa S, et al. Clinical, neurophysiological, and skin biopsy findings in peripheral neuropathy associated with hepatitis C virus-related cryoglobulinemia. J Neurol. 2014;261:725–31.
Costa J, Resende C, De Carvalho M. Motor-axonal polyneuropathy associated with hepatitis C virus. Eur J Neurol. 2003;10:183–5.
Ammendola A, Sampaolo S, Migliaresi S, et al. Autonomic neuropathy in mixed cryoglobulinemia. J Neurol. 2007;254:215–9.
Tabor E. Guillain-Barré syndrome and other neurologic syndromes in hepatitis A, B, and non-A, non-B. J Med Virol. 1987;21:207–16.
Khiani V, Kelly T, Shibli A, et al. Acute inflammatory demyelinating polyneuropathy associated with pegylated interferon alpha 2a therapy for chronic hepatitis C virus infection. World J Gastroenterol. 2008;14:318–21.
De Klippel N, Hautekeete ML, De Keyser J, et al. Guillain-Barré syndrome as the presenting manifestation of hepatitis C infection. Neurology. 1993;43:2143.
Corcia P, Barbereau D, Guennoc AM, et al. Improvement of a CIDP associated with hepatitis C virus infection using antiviral therapy. Neurology. 2004;63:179–80.
Hirotani M, Nakano H, Ura S, et al. Chronic inflammatory demyelinating polyneuropathy after treatment with interferon-alpha. Intern Med. 2009;48:373–5.
Caporale CM, Capasso M, Ragno M, et al. Lewis-Sumner syndrome in hepatitis C virus infection: a possible pathogenetic association with therapeutic problems. Muscle Nerve. 2006;34:116–21.
Mariotto S, Ferrari S, Monaco S. HCV-related central and peripheral nervous system demyelinating disorders. Inflamm Allergy Drug Targets. 2014;13:299–304.
Dammacco F, Lauletta G, Russi S, et al. Clinical practice: hepatitis C virus infection, cryoglobulinemia and cryoglobulinemic vasculitis. Clin Exp Med. 2019;19:1–21.
Benstead TJ, Chalk CH, Parks NE. Treatment for cryoglobulinemic and non-cryoglobulinemic peripheral neuropathy associated with hepatitis C virus infection. Cochrane Database Syst Rev. 2014;(12):CD010404.
Tu W, Johnson E, Fujiwara E, Gill MJ, et al. Predictive variables for peripheral neuropathy in treated HIV-1 infection revealed by machine learning. AIDS. 2021;35(11):1785–93. https://doi.org/10.1097/QAD.0000000000002955. Epub ahead of print.
Ferrari S, Vento S, Monaco S, et al. Human immunodeficiency virus-associated peripheral neuropathies. Mayo Clin Proc. 2006;2:213–9.
Schütz SG, Robinson-Papp J. HIV-related neuropathy: current perspectives. HIV AIDS. 2013;5:243–51.
Cherry CL, Affandi JS, Imran D, et al. Age and height predict neuropathy risk in patients with HIV prescribed stavudine. Neurology. 2009;73:315–20.
Ellis RJ, Rosario D, Clifford DB, et al.; CHARTER Study Group. Continued high prevalence and adverse clinical impact of human immunodeficiency virus-associated sensory neuropathy in the era of combination antiretroviral therapy: the CHARTER study. Arch Neurol. 2010;67:552–58.
Robinson-Papp J, Sharma S, Simpson DM, et al. Autonomic dysfunction is common in HIV and associated with distal symmetric polyneuropathy. J Neurovirol. 2013;19:172–80.
Cornblath DR, McArthur JC. Predominantly sensory neuropathy in patients with AIDS and AIDS-related complex. Neurology. 1988;38:794–6.
Rizzuto N, Cavallaro T, Monaco S, et al. Role of HIV in the pathogenesis of distal symmetrical peripheral neuropathy. Acta Neuropathol. 1995;(90):244–50.
Polydefkis M, Yiannoutsos CT, Cohen BA, et al. Reduced intraepidermal nerve fiber density in HIV-associated sensory neuropathy. Neurology. 2002;58:115–9.
Moss PJ, Huang W, Dawes J, et al. Macrophage-sensory neuronal interaction in HIV-1 gp120-induced neurotoxicity. Br J Anaesth. 2015;114:499–508.
Roda RH, Bargiela D, Chen W, et al. Large mitochondrial DNA deletions in HIV sensory neuropathy. Neurology. 2021;97(2):e156–65. https://doi.org/10.1212/WNL.0000000000012142. Epub ahead of print.
Mou J, Paillard F, Turnbull B, et al. Efficacy of Qutenza® (capsaicin) 8% patch for neuropathic pain: a meta-analysis of the Qutenza clinical trials database. Pain. 2013;154:1632–9.
Simpson DM, Schifitto G, Clifford DB, Murphy TK, Durso-De Cruz E, Glue P, Whalen E, Emir B, Scott GN, Freeman R, 1066 HIV Neuropathy Study Group. Pregabalin for painful HIV neuropathy: a randomized, double-blind, placebo-controlled trial. Neurology. 2010;74(5):413–20.
Abrams DI, Jay CA, Shade SB, et al. Cannabis in painful HIV-associated sensory neuropathy: a randomized placebo-controlled trial. Neurology. 2007;68:515–52.
Schifitto G, Yiannoutsos C, Simpson DM, et al.; AIDS Clinical Trials Group Team 291. Long-term treatment with recombinant nerve growth factor for HIV-associated sensory neuropathy. Neurology. 2001;57:1313–16.
Hiraga A, Kuwabara S, Nakamura A, et al. Fisher/Gullain-Barré overlap syndrome in advanced AIDS. J Neurol Sci. 2007;258:148–50.
Brannagan TH 3rd, Zhou Y. HIV-associated Guillain-Barré syndrome. J Neurol Sci. 2003;208:39–42.
Ferrari S, Lanzafame M, Faggian F, et al. Painful neuropathy vasculitis in 2 patients with long-standing human immunodeficiency virus-1 infection. Scand J Infect Dis. 2004;36:392–293.
Miller RF, Fox JD, Thomas P, et al. Acute lumbosacral polyradiculopathy due to cytomegalovirus in advanced HIV disease: CSF findings in 17 patients. J Neurol Neurosurg Psychiatry. 1996;61:456–60.
Kameda K, Shirano M, Hadano Y, et al. Cytomegalovirus polyradiculopathy in three Japanese patients with AIDS. Intern Med. 2015;54:513–8.
Ghrenassia E, Martis N, Boyer J, et al. The diffuse infiltrative lymphocytosis syndrome (DILS). A comprehensive review. J Autoimmun. 2015;59:19–25.
Moulignier A, Authier FJ, Baudrimont M, et al. Peripheral neuropathy in human immunodeficiency virus-infected patients with the diffuse infiltrative lymphocytosis syndrome. Ann Neurol. 1997;41:438–45.
WHO. Global leprosy update, 2013; reducing disease burden. Wkly Epidemiol Rec. 2014;89:389–400.
Ridley DS, Jopling WH. Classification of leprosy according to immunity. A five-group system. Int J Lepr Other Mycobact Dis. 1966;34:255–73.
de Freitas MR, Nascimento OJ, Quaglino EA, et al. Small-fiber polyneuropathy in leprosy without skin changes: study of 17 cases. Arq Neuropsiquiatr. 2003;61:542–5.
Visser LH, Jain S, Lokesh B, et al. Morphological changes of the epineurium in leprosy: a new finding detected by high-resolution sonography. Muscle Nerve. 2012;46:38–41.
Kulshreshtha D, Malhotra KP, Malhotra HS, et al. Mandating nerve biopsy: a step towards personalizing therapy in pureneuritic leprosy. J Peripher Nerv Syst. 2018;23:190–6.
Dryden MS, Saeed K, Ogborn S, et al. Lyme borreliosis in southern United Kingdom and a case for a new syndrome, chronic arthropod-borne neuropathy. Epidemiol Infect. 2015;143:561–72.
van Erp WS, Bakker NA, Aries MJ, et al. Opsoclonus and multiple cranial neuropathy as a manifestation of neuroborreliosis. Neurology. 2011;77:1013–4.
Muley SA, Parry GJ. Antibiotic responsive demyelinating neuropathy related to Lyme disease. Neurology. 2009;72:1786–7.
Halperin JJ, Little BW, Coyle PK, et al. Lyme disease: cause of a treatable peripheral neuropathy. Neurology. 1987;37:1700–6.
Mygland A, Skarpaas T, Ljøstad U. Chronic polyneuropathy and Lyme disease. Eur J Neurol. 2006;13:1213–5.
Logigian EL, Kaplan RF, Steere AC. Chronic neurologic manifestations of Lyme disease. N Engl J Med. 1990;323:1438–44.
Latronico N, Bolton CF. Critical illness polyneuropathy and myopathy: a major cause of muscle weakness and paralysis. Lancet Neurol. 2011;10(10):931–41. https://doi.org/10.1016/S1474-4422(11)70178-8.
Cabañes-Martínez L, Villadóniga M, González-Rodríguez L, et al. Neuromuscular involvement in COVID-19 critically ill patients. Clin Neurophysiol. 2020;131(12):2809–16. https://doi.org/10.1016/j.clinph.2020.09.017.
Frithiof R, Rostami E, Kumlien E, et al. Critical illness polyneuropathy, myopathy and neuronal biomarkers in COVID-19 patients: a prospective study. Clin Neurophysiol. 2021;132(7):1733–40. https://doi.org/10.1016/j.clinph.2021.03.016.
Filosto M, Cotti Piccinelli S, Gazzina S, et al. Guillain-Barré syndrome and COVID-19: an observational multicentre study from two Italian hotspot regions. J Neurol Neurosurg Psychiatry. 2021;92(7):751–6. https://doi.org/10.1136/jnnp-2020-324837.
Gigli GL, Bax F, Marini A, Pellitteri G, Scalise A, Surcinelli A, Valente M. Guillain-Barré syndrome in the COVID-19 era: just an occasional cluster? J Neurol. 2021;268(4):1195–7. https://doi.org/10.1007/s00415-020-09911-3.
Fragiel M, Miró Ò, Llorens P, et al. Incidence, clinical, risk factors and outcomes of Guillain-Barré in Covid-19. Ann Neurol. 2021;89(3):598–603. https://doi.org/10.1002/ana.25987.
Keddie S, Pakpoor J, Mousele C, et al. Epidemiological and cohort study finds no association between COVID-19 and Guillain-Barré syndrome. Brain. 2021;144(2):682–93. https://doi.org/10.1093/brain/awaa433.
Aladawi M, Elfil M, Abu-Esheh B, et al. Guillain Barre syndrome as a complication of COVID-19: a systematic review. Can J Neurol Sci. 2021;5:1–35. https://doi.org/10.1017/cjn.2021.102. Epub ahead of print. PMID: 33949300.
Uncini A, Foresti C, Frigeni B, et al. Electrophysiological features of acute inflammatory demyelinating polyneuropathy associated with SARS-CoV-2 infection. Neurophysiol Clin. 2021;51(2):183–91. https://doi.org/10.1016/j.neucli.2021.02.001.
Abu-Rumeileh S, Garibashvili T, Ruf W, et al. Exacerbation of chronic inflammatory demyelinating polyneuropathy in concomitance with COVID-19. J Neurol Sci. 2020;418:117106. https://doi.org/10.1016/j.jns.2020.117106. Epub 2020 Sep 2.
Van Looy E, Veenker L, Steyaert A, et al. COVID-19-induced exacerbation of chronic inflammatory demyelinating polyneuropathy. J Neurol. 2021;268(9):3129–31. https://doi.org/10.1007/s00415-021-10417-9. Epub ahead of print.
Brugliera L, Filippi M, Del Carro U, et al. Nerve compression injuries after prolonged prone position ventilation in patients with SARS-CoV-2: a case series. Arch Phys Med Rehabil. 2021;102(3):359–62. https://doi.org/10.1016/j.apmr.2020.10.131.
Malik GR, Wolfe AR, Soriano R, Rydberg L, et al. Injury-prone: peripheral nerve injuries associated with prone positioning for COVID-19-related acute respiratory distress syndrome. Br J Anaesth. 2020;125(6):e478–80. https://doi.org/10.1016/j.bja.2020.08.045.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2022 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Ferrari, S., Mariotto, S., Cavallaro, T., Fabrizi, G.M., Monaco, S. (2022). Infectious Neuropathies. In: Angelini, C. (eds) Acquired Neuromuscular Disorders. Springer, Cham. https://doi.org/10.1007/978-3-031-06731-0_19
Download citation
DOI: https://doi.org/10.1007/978-3-031-06731-0_19
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-031-06730-3
Online ISBN: 978-3-031-06731-0
eBook Packages: MedicineMedicine (R0)